Abstract Metastatic castration-resistant prostate cancer is typically lethal, exhibiting intrinsic or acquired resistance to second-generation androgen-targeting therapies and minimal response to immune checkpoint inhibitors 1 . Cellular programs driving resistance in both cancer and immune cells re...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!